American Association Of Kidney Patients Announces 2007 Kidney Beginnings: Live Program
January 8, 2007 – 2:43 pm | posted in Urology / NephrologyThe American Association of Kidney Patients (AAKP) is pleased to once again partner with Ortho Biotech Products, L.P., to host the popular Kidney Beginnings: Live program.
Kidney Beginnings: Live is a FREE, educational program developed for those who have recently been diagnosed with reduced kidney function, those with risk factors for chronic kidney disease (CKD) such as diabetes and/or hypertension or those who have a family history of kidney disease.
“Kidney Beginnings: Live is an exceptional program. The amount of information these local healthcare professionals offer the attendees is outstanding,” said Kris Robinson, AAKP Executive Director and CEO. “If you have been diagnosed with CKD, I would strongly urge you to attend this educational event.”
AAKP is pleased to host the program in 12 cities across the United States including: Tampa, FL; St. Louis; Nashville, TN; Baton Rouge, LA; and Cleveland. Please visit http://www.aakp.org for a complete list of the 2007 Kidney Beginnings: Live locations.
Kidney Beginnings: Live is an extension of the Kidney Beginnings educational series which includes:
– Kidney Beginnings: The Magazine
– Kidney Beginnings: A Patients Guide to Living with Reduced Kidney Function
– Kidney Beginnings: The Electronic Newsletter.
For more information about Kidney Beginnings: Live or any of the items in the Kidney Beginnings series, please contact AAKP at (800) 749-AAKP or info@aakp.org.
AAKP is the voluntary, patient organization, which for more than 35 years, has been dedicated to improving the lives of fellow kidney patients and their families by helping them deal with the physical, emotional and social impact of kidney disease. The programs offered by AAKP inform and inspire patients and their families to better understand their condition, adjust more readily to their circumstances, and assume more normal, productive lives in their communities.
Popularity: 2% [?]
You must be logged in to post a comment.